Wayne State University

Aim Higher

Institutional Review Board

IRB Membership

Wayne State University has five Institutional Review Boards (IRBs).  

Individual IRB membership lists can be requested via email through Lana Streeter, Program Project Assistant, ao4851@wayne.edu.

The IRB Chair

The IRB Chair is charged to review and approve new protocols and amendments to existing protocols that meet criteria for expedited review, and grant exemptions for research submissions that meet the rigid standards thereof.  The IRB Chair, or Vice Chair, is required to manage activities associated with applications for Single Time Use of a Test Article, so-called “compassionate use”. The IRB Chair is also named, and his/her telephone number listed on all WSU and Affiliate consent forms, as the contact person for research questions that may arise from study participants.

Adult and Pediatric Behavioral/Social Science Research

The Behavioral IRB (B3) is responsible for reviewing all behavioral and social science research in adults and minors. This committee convenes on the third Thursday of the month. Please review the meeting dates and submission deadlines for additional information.

Adult and Pediatric Biomedical Research

There are four IRBs that review medical protocols involving adult participants (M1, MP2, MP4 and PH1). Two of these IRBs (MP2 and MP4) are qualified to review research involving minors (individuals younger than 18 years of age).

The M1 IRB convenes on the first Thursday of the month, the MP2 IRB convenes on the second Thursday of the month, and the MP4 IRB convenes on the fourth Thursday of the month.  The PH1 IRB convenes every Friday (see below for more details). Please review the meeting dates and submission deadlines for additional information.
 

PH1 IRB for Phase I Clinical Trials

The PH1 IRB specializes in the review of industry-sponsored Phase I clinical trials. All new submissions for industry-sponsored Phase I trials must be submitted to this committee. There are three objectives of this initiative: rapid turnaround of submissions; support for investigators, including new investigators, to increase their activities in this area of clinical research; and enhancement of some of the aims of the Clinical and Translational Science Award (CTSA) initiative. 
PH1 features weekly meetings and a rapid turnaround of submissions. All communications will be electronic. Submissions must use the current IRB forms available on the IRB website. The committee’s Research Compliance Specialist, Barbara Lloyd, receives submissions electronically at PH1board@wayne.edu, thoroughly pre-reviews them for completeness and clarity, and works closely with the investigator to optimize the submission for review by PH1. Memos of the committee’s decisions will be prepared quickly and be provided electronically to the investigator within days of the meeting. 
In order to provide these services, there are fees over and above the usual clinical trials fees charged by the IRB (FY 2009 PH1 fees).   For more information, please contact Barbara Lloyd at blloyd@wayne.edu or the Director - Responsible Conduct of Research, Gayle Kusch, at gayle.kusch@wayne.edu.